THNR vs. PSIL
THNR (Amplify Weight Loss Drug & Treatment ETF) and PSIL (AdvisorShares Psychedelics ETF) are both Health & Biotech Equities funds. THNR is passively managed, while PSIL is actively managed. Over the past year, THNR returned 9.10% vs 72.93% for PSIL. At a 0.34 correlation, their price movements are largely independent. THNR charges 0.59%/yr vs 1.00%/yr for PSIL.
Performance
THNR vs. PSIL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, THNR achieves a -5.20% return, which is significantly lower than PSIL's 23.33% return.
THNR
- 1D
- -1.47%
- 1M
- -2.91%
- YTD
- -5.20%
- 6M
- -3.73%
- 1Y
- 9.10%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PSIL
- 1D
- -3.49%
- 1M
- 5.19%
- YTD
- 23.33%
- 6M
- 29.24%
- 1Y
- 72.93%
- 3Y*
- 10.51%
- 5Y*
- —
- 10Y*
- —
THNR vs. PSIL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
THNR Amplify Weight Loss Drug & Treatment ETF | -5.20% | 13.65% | -10.36% |
PSIL AdvisorShares Psychedelics ETF | 23.33% | 74.55% | -9.40% |
Correlation
The correlation between THNR and PSIL is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.36 |
Correlation (All Time) Calculated using the full available price history since May 22, 2024 | 0.34 |
THNR vs. PSIL - Sectors Allocation Comparison
Sectors
THNR
PSIL
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
THNR
PSIL
Financial Services
THNR
PSIL
-
Basic Materials
THNR
-
PSIL
-
Communication Services
THNR
-
PSIL
-
Consumer Cyclical
THNR
-
PSIL
-
Consumer Defensive
THNR
-
PSIL
-
Energy
THNR
-
PSIL
-
Industrials
THNR
-
PSIL
-
Real Estate
THNR
-
PSIL
-
Technology
THNR
-
PSIL
-
Utilities
THNR
-
PSIL
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
THNR vs. PSIL — Risk / Return Rank
THNR
PSIL
THNR vs. PSIL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and AdvisorShares Psychedelics ETF (PSIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| THNR | PSIL | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.48 | 1.76 | -1.28 |
Sortino ratioReturn per unit of downside risk | 0.81 | 2.30 | -1.49 |
Omega ratioGain probability vs. loss probability | 1.10 | 1.30 | -0.20 |
Calmar ratioReturn relative to maximum drawdown | 0.76 | 3.80 | -3.04 |
Martin ratioReturn relative to average drawdown | 1.75 | 8.06 | -6.31 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| THNR | PSIL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.48 | 1.76 | -1.28 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | -0.41 | +0.32 |
Drawdowns
THNR vs. PSIL - Drawdown Comparison
The maximum THNR drawdown since its inception was -32.51%, smaller than the maximum PSIL drawdown of -92.72%. Use the drawdown chart below to compare losses from any high point for THNR and PSIL.
Loading charts...
Drawdown Indicators
| THNR | PSIL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.51% | -92.72% | +60.21% |
Max Drawdown (1Y)Largest decline over 1 year | -12.06% | -20.38% | +8.32% |
Max Drawdown (3Y)Largest decline over 3 years | — | -64.62% | — |
Current DrawdownCurrent decline from peak | -13.00% | -76.01% | +63.01% |
Average DrawdownAverage peak-to-trough decline | -12.24% | -76.76% | +64.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.26% | 9.62% | -4.36% |
Volatility
THNR vs. PSIL - Volatility Comparison
The current volatility for Amplify Weight Loss Drug & Treatment ETF (THNR) is 5.16%, while AdvisorShares Psychedelics ETF (PSIL) has a volatility of 9.35%. This indicates that THNR experiences smaller price fluctuations and is considered to be less risky than PSIL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| THNR | PSIL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.16% | 9.35% | -4.19% |
Volatility (6M)Calculated over the trailing 6-month period | 13.55% | 28.02% | -14.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.15% | 41.78% | -22.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.37% | 63.17% | -43.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.37% | 63.17% | -43.80% |
THNR vs. PSIL - Expense Ratio Comparison
THNR has a 0.59% expense ratio, which is lower than PSIL's 1.00% expense ratio.
Dividends
THNR vs. PSIL - Dividend Comparison
THNR's dividend yield for the trailing twelve months is around 1.73%, less than PSIL's 8.10% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
PSIL AdvisorShares Psychedelics ETF | 8.10% | 10.95% | 1.49% | 0.24% | 2.91% |
THNR Amplify Weight Loss Drug & Treatment ETF | 1.73% | 1.64% | 0.98% | 0.00% | 0.00% |
Frequently Asked Questions
THNR and PSIL have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PSIL has higher volatility (9.35%) compared to THNR (5.16%). In terms of maximum drawdown, THNR dropped -32.51% vs PSIL's -92.72%.
On 1-year performance, PSIL leads with 72.93% vs 9.10% for THNR. On fees, THNR is cheaper at 0.59% per year. On volatility, THNR has been the lower-risk option at 5.16%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, PSIL has performed better with a 72.93% return vs 9.10%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
THNR is cheaper with a 0.59% expense ratio, compared with 1.00% for PSIL.
PSIL has the higher dividend yield at 8.10%, compared with 1.73% for THNR.
They also come from different issuers: Amplify and AdvisorShares. Their fees differ too: 0.59% for THNR and 1.00% for PSIL.
PSIL currently has the higher Sharpe Ratio (1.76 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for THNR and PSIL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer